TBPH

Theravance Biopharma, Inc. (NASDAQ:TBPH) is a biopharmaceutical company founded in 2013 and incorporated in the Cayman Islands with operations based in George Town. The company emerged as a spinoff focused on developing and commercializing respiratory medicines and other therapeutic treatments. Theravance operates primarily in the United States, Europe, and Asia, with a concentrated focus on respiratory diseases, particularly chronic obstructive pulmonary disease (COPD), and rare neurological conditions. The company has transitioned from a broad research-focused organization to a more streamlined entity concentrating on its core commercial asset and late-stage pipeline candidates.